Engleman Edgar's Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Nov 22, 2023
- Accession no.
- 0001209191-23-056548
- Filed
- Nov 22, 2023
- Trade date
- Nov 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.75K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Engleman EdgarCIK 0001227162 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | Common Stock | SSaleDisposed | −1,707 | $0.90 | −$1,536.3 | 1,952,302 | Indirect | |
| Nov 21, 2023 | Common Stock | SSaleDisposed | −236 | $0.90 | −$212.4 | 269,587 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.